JP2021004195A - Agent for preventing and treating fish disease - Google Patents

Agent for preventing and treating fish disease Download PDF

Info

Publication number
JP2021004195A
JP2021004195A JP2019117995A JP2019117995A JP2021004195A JP 2021004195 A JP2021004195 A JP 2021004195A JP 2019117995 A JP2019117995 A JP 2019117995A JP 2019117995 A JP2019117995 A JP 2019117995A JP 2021004195 A JP2021004195 A JP 2021004195A
Authority
JP
Japan
Prior art keywords
fish
lao
activity
concentration
sds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019117995A
Other languages
Japanese (ja)
Inventor
洋一郎 木谷
Yoichiro Kitani
洋一郎 木谷
優斗 小坂
Yuto Kosaka
優斗 小坂
鈴木 信雄
Nobuo Suzuki
信雄 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanazawa University NUC
Original Assignee
Kanazawa University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanazawa University NUC filed Critical Kanazawa University NUC
Priority to JP2019117995A priority Critical patent/JP2021004195A/en
Publication of JP2021004195A publication Critical patent/JP2021004195A/en
Pending legal-status Critical Current

Links

Abstract

To provide an agent for preventing and treating fish disease that has low concentration and has small environmental load, and also has excellent safety in operation.SOLUTION: The agent is used for preventing and treating the infection of fish disease in a fish, and contains salt of monoalkyl sulfate or benzalkonium chloride.SELECTED DRAWING: Figure 1

Description

本発明は魚類を細菌感染症等の疾病から予防あるいは、その治療に有効な魚病の予防及び治療剤に関する。 The present invention relates to a preventive and therapeutic agent for fish diseases that are effective in preventing or treating fish from diseases such as bacterial infections.

養殖場や水族館等においては飼育密度が高く、魚類が魚病に感染しやすく、その予防や治療が重要となる。
現在、疾病予防に対するワクチンが使用され、治療に各種抗生物質等が使用されているが、投与等の操作が煩雑であり、耐性菌の発生も問題となる。
In aquaculture farms and aquariums, the breeding density is high, and fish are easily infected with fish diseases, so prevention and treatment are important.
Currently, vaccines for disease prevention are used, and various antibiotics and the like are used for treatment, but operations such as administration are complicated, and the development of resistant bacteria is also a problem.

特許文献1には、藻類の抽出物と乳酸球菌又はポリフェノールを含有する魚類の感染予防・治療剤を開示する。
しかし、同公報に開示する予防・治療剤は比較的高濃度であるとともに、経口法,薬浴法を用いるものであり、投与操作が大変である。
Patent Document 1 discloses an infection preventive / therapeutic agent for fish containing an algae extract and lactic acid cocci or polyphenols.
However, the prophylactic / therapeutic agents disclosed in the same gazette have a relatively high concentration and use the oral method and the drug bath method, which makes the administration operation difficult.

これに対して本発明者らは、魚類が本来持っている生体防御機構を利用した魚病対策を検討した。
例えば、本発明者らが研究成果として発表した非特許文献1に開示するように、魚類の体表粘液から抗菌タンパク質としてL−アミノ酸オキシダーゼ(LAO)が同定され、血清中からもL−アミノ酸オキシダーゼが同定されている。
キジハタ血清中のLAOは約450kDaで約70kDaサブユニットの6量体であることが示唆されている。
このLAOは過酸化水素を介して抗菌活性を示すものと推定されることから、このLAO活性を刺激し、増強できる物質が得られれば、魚病対策に有効であると検討した結果、本発明に至った。
On the other hand, the present inventors have investigated measures against fish diseases using the biological defense mechanism originally possessed by fish.
For example, as disclosed in Non-Patent Document 1 published by the present inventors as a research result, L-amino acid oxidase (LAO) was identified as an antibacterial protein from the body surface mucus of fish, and L-amino acid oxidase was also identified in serum. Has been identified.
It has been suggested that LAO in Hong Kong grouper serum is about 450 kDa and is a hexamer of about 70 kDa subunits.
Since this LAO is presumed to exhibit antibacterial activity via hydrogen peroxide, it was examined that if a substance capable of stimulating and enhancing this LAO activity could be obtained, it would be effective as a countermeasure against fish diseases. It came to.

特開2004−307346号公報Japanese Unexamined Patent Publication No. 2004-307346

木谷洋一郎,小坂優斗,「キジハタEpinephelus akaara血清に含まれるL−アミノ酸オキシダーゼについて」平成30年度日本水産学会春季大会,東京海洋大学,東京都(2018.3.26−30)Yoichiro Kitani, Yuto Kosaka, "L-amino-acid oxidase contained in serum of Hong Kong grouper Epinephelus akaara" 2018 Spring Meeting of the Japanese Society of Fisheries Science, Tokyokaiyo University, Tokyo (2018.3.26-30)

本発明は、低濃度で環境負荷が低く、操作安全性にも優れた魚病の予防及び治療剤の提供を目的とする。 An object of the present invention is to provide a preventive and therapeutic agent for fish diseases having a low concentration, a low environmental load, and excellent operational safety.

本発明に係る魚病の予防及び治療剤は、魚類における魚病の感染予防又は治療に用いるための、モノアルキル硫酸エステルの塩又は塩化ベンザルコニウムを含有する。
ここで、前記モノアルキル硫酸エステルの塩はラウリル硫酸ナトリウム又はラウリル硫酸アンモニウムであるのが好ましい。
The fish disease prophylaxis and therapeutic agent according to the present invention contains a salt of monoalkyl sulfate or benzalkonium chloride for use in the prevention or treatment of fish disease infection in fish.
Here, the salt of the monoalkyl sulfate ester is preferably sodium lauryl sulfate or ammonium lauryl sulfate.

モノアルキル硫酸エステルの塩は、陰イオン性に属する界面活性剤である。
ラウリル硫酸ナトリウムは、ドデシル硫酸ナトリウム(SDS)とも称され、比較的保存安定性に優れ、人に対する安全性も高い。
塩化ベンザルコニウム(benzalkonium chloride)は、陽イオン界面活性剤の一種である。
The salt of monoalkyl sulfate ester is a surfactant belonging to anionic properties.
Sodium lauryl sulfate, also called sodium dodecyl sulfate (SDS), has relatively excellent storage stability and is highly safe for humans.
Benzalkonium chloride is a type of cationic surfactant.

本発明に係る魚病の予防及び治療剤の作用を以下、説明する。
魚類の表皮細胞や血清中に生体防御物質としてL−アミノ酸オキシダーゼ(LAO)を有し、このLAOは図8に示すように基質L−アミノ酸に作用して過酸化水素を産生し、この過酸化水素より抗菌作用が生じるものと推定される。
図1にて「FAD」は、フラビンアデニンジヌクレオチドの略であり、酸化還元反応の補因子である。
本発明に係る魚病の予防及び治療剤は、このLAOの活性を刺激し、抗菌活性が増強されるものと推定される。
詳細は後述するが、本発明に係る薬剤は0.5〜5mM程度の極薄い濃度で抗菌活性効果が認められる。
The action of the preventive and therapeutic agent for fish disease according to the present invention will be described below.
It has L-amino acid oxidase (LAO) as a biological defense substance in the epidermal cells and serum of fish, and this LAO acts on the substrate L-amino acid to produce hydrogen peroxide as shown in FIG. 8, and this peroxidation It is presumed that hydrogen has an antibacterial effect.
In FIG. 1, "FAD" is an abbreviation for flavin adenine dinucleotide and is a cofactor for redox reaction.
It is presumed that the preventive and therapeutic agent for fish diseases according to the present invention stimulates the activity of LAO and enhances the antibacterial activity.
Although the details will be described later, the drug according to the present invention has an antibacterial activity effect at an extremely thin concentration of about 0.5 to 5 mM.

本発明に係る魚類の細菌感染症を予防及び治療するための薬剤は、使用する濃度が薄いので環境負荷が低い。
また、これらは陰イオン性又は陽イオンの界面活性剤でもあることから、長期保存が可能であり、取り扱い時の人に対する安全性にも問題がない。
また、水槽内で使用した場合には、この水槽内の洗浄作用も期待できる。
The agent for preventing and treating a bacterial infection in fish according to the present invention has a low environmental load because the concentration used is low.
Further, since these are also anionic or cationic surfactants, they can be stored for a long period of time, and there is no problem in safety to humans during handling.
Further, when used in a water tank, a cleaning action in the water tank can be expected.

魚病細菌Vibrio anguillarum及びAeromonas salmonicidaに対する抗菌活性試験結果を示す。The results of antibacterial activity tests against the fish disease bacteria Vibrio anguillarum and Aeromonas salmonicida are shown. SDS濃度に対するLAO活性の試験結果を示す。The test result of LAO activity with respect to SDS concentration is shown. NaCl濃度に対するLAO活性の試験結果を示す。The test result of LAO activity with respect to the NaCl concentration is shown. SDS濃度に対するLAO活性の試験結果その2を示す。The test result 2 of the LAO activity with respect to the SDS concentration is shown. SDS濃度に対するLAO活性の試験結果その3を示す。The test result 3 of the LAO activity with respect to the SDS concentration is shown. ラウリル硫酸アンモニウム濃度に対するLAO活性の試験結果を示す。The test result of LAO activity with respect to the concentration of ammonium lauryl sulfate is shown. 塩化ベンザルコニウム濃度に対するLAO活性の試験結果を示す。The test result of LAO activity with respect to the concentration of benzalkonium chloride is shown. LAOが抗菌活性を示す反応系の説明図である。It is explanatory drawing of the reaction system which LAO shows antibacterial activity.

本発明に係る魚病の予防及び治療剤の抗菌活性について試験評価したので以下、説明する。
キジハタ血清にはL−アミノ酸オキシダーゼ(以下、必要に応じて単にLAOと表現する)が含まれ、このLAOがL−アミノ酸基質に作用することで過酸化水素を介した抗菌活性を示す。
そこで、次のような試験を実施した。
ミューラーヒントン培地(NaCl不含)にキジハタ血清の2倍段階希釈系列を調製し、同培地で1×10に調整した魚病細菌Vibrio anguillarumまたはAeromonas salmonicidaを加えた。
これを基本とし、培地中に終濃度0.04%となるようにドデシル硫酸ナトリウム(SDS)を加えた群、これに終濃度20unit/mLとなるようにカタラーゼを加えた群、同濃度のカタラーゼのみを加えた群を同時に培養した。
カタラーゼはキジハタ血清中に含まれるL−アミノ酸オキシダーゼが産生する過酸化水素の消尽を目的として加えた。
これらを20℃で16時間培養後、細菌の増殖が抑えられていると、培地に濁りが生じないことから、培地の混濁を目視で認めない最大希釈倍率を抗菌活性の値として評価した。
その結果、図1に示すようにVibrio anguillarumに対してSDS添加群における抗菌活性は4096倍以上を示したが、そのほかの群における抗菌活性は検出されなかった。
また、Aeromonas salmonicidaに対してはSDS添加群の抗菌活性は2048倍を示し、SDSとカタラーゼを同時に添加した群では抗菌活性が認められなかった。
試薬不添加群およびカタラーゼのみ添加群で32倍の抗菌活性を示したが、これはSDSで不活化するそのほかの抗菌物質によるものであると予想された。
以上の結果から、キジハタ血清はSDSで抗菌活性が増強し、かつカタラーゼ添加でその活性が減少することが確かめられた。
すなわち、血清単体もしくはSDS単体では抗菌活性を示さないが、血清中にSDSが存在することで過酸化水素を介した強力な抗菌作用を示すことが確認された。
The antibacterial activity of the preventive and therapeutic agent for fish disease according to the present invention has been tested and evaluated, and will be described below.
Hong Kong grouper serum contains L-amino acid oxidase (hereinafter, simply referred to as LAO if necessary), and this LAO acts on the L-amino acid substrate to exhibit antibacterial activity via hydrogen peroxide.
Therefore, the following test was conducted.
Mueller Hinton the medium (NaCl-free) to prepare a 2-fold serial dilution series of Kijihata serum were added 1 × 10 5 fish diseases bacteria were adjusted to Vibrio anguillarum or Aeromonas salmonicida in the same medium.
Based on this, a group in which sodium dodecyl sulfate (SDS) was added to a final concentration of 0.04% in the medium, a group in which catalase was added to a final concentration of 20 units / mL, and a catalase having the same concentration. The group to which the catalase was added was cultured at the same time.
Catalase was added for the purpose of exhausting hydrogen peroxide produced by L-amino acid oxidase contained in Hong Kong grouper serum.
After culturing these at 20 ° C. for 16 hours, if the growth of bacteria was suppressed, the medium did not become turbid. Therefore, the maximum dilution ratio at which turbidity of the medium was not visually observed was evaluated as the value of antibacterial activity.
As a result, as shown in FIG. 1, the antibacterial activity in the SDS-added group was 4096 times or more against Vibrio anguillarum, but the antibacterial activity in the other groups was not detected.
In addition, the antibacterial activity of the SDS-added group was 2048 times higher than that of Aeromonas salmonicida, and no antibacterial activity was observed in the group to which SDS and catalase were added at the same time.
The reagent-free group and the catalase-only group showed 32-fold antibacterial activity, which was expected to be due to other antibacterial substances inactivated by SDS.
From the above results, it was confirmed that the antibacterial activity of Hong Kong grouper serum was enhanced by SDS and that the activity was decreased by the addition of catalase.
That is, it was confirmed that the serum alone or SDS alone does not show antibacterial activity, but the presence of SDS in the serum shows a strong antibacterial action via hydrogen peroxide.

次に、いろいろな試薬を用いてLAO活性を評価したので以下、説明する。 Next, the LAO activity was evaluated using various reagents, which will be described below.

これまでに本発明者らにより、NaClの添加によりLAO活性の増強が認められることから、ドデシル硫酸ナトリウム(SDS)とNaClの濃度を変化させながら、それらを比較評価した。
<LAO活性の測定方法>
適宜1M Tris−HCl緩衝液(pH7.5)で希釈した血清25マイクロリットルに塩化ナトリウム水溶液もしくはドデシル硫酸ナトリウム水溶液25マイクロリットルを終濃度0−2Mもしくは0−1.4mMとなるよう加えた。
次にオルトフェニレンジアミン0.25mg/mLおよび西洋ワサビペルオキシダーゼ0.01unit/mLを含む1M Tris−HCl緩衝液(pH7.5)50マイクロリットルを加え150分間37℃で反応させた。
反応後、100マイクロリットルの1M硫酸を加え反応を停止させ、分光光度計で492nmの吸光度を測定した。
活性の評価には0−0.5mMに段階希釈した過酸化水素を試料として測定し、検量線から得られた過酸化水素産生量と反応時間から活性(unit)を推定した。
Since the addition of NaCl has been observed to enhance LAO activity by the present inventors, they were compared and evaluated while changing the concentrations of sodium dodecyl sulfate (SDS) and NaCl.
<Measurement method of LAO activity>
To 25 microliters of serum diluted with 1 M Tris-HCl buffer (pH 7.5), 25 microliters of an aqueous sodium chloride solution or an aqueous sodium dodecyl sulfate solution was added to a final concentration of 0-2M or 0-1.4 mM.
Next, 50 microliters of 1M Tris-HCl buffer (pH 7.5) containing 0.25 mg / mL of ortho-phenylenediamine and 0.01 unit / mL of horseradish peroxidase were added and reacted at 37 ° C. for 150 minutes.
After the reaction, 100 microliters of 1M sulfuric acid was added to stop the reaction, and the absorbance at 492 nm was measured with a spectrophotometer.
To evaluate the activity, hydrogen peroxide serially diluted to 0-0.5 mM was measured as a sample, and the activity (unit) was estimated from the amount of hydrogen peroxide produced and the reaction time obtained from the calibration curve.

図2にSDS濃度変化に対するLAO活性を示し、図3にNaCl濃度変化に対するLAO活性を示す。
図2と図3とを比較すると、NaClは0.5Mの濃度以上にしないと、LAO活性が高活性にならないのに対して、SDSは0.5mM〜1.4mMの薄い濃度、即ちNaClの約1/1000以下の低濃度にて、LAOが高活性を示した。
FIG. 2 shows the LAO activity for changes in SDS concentration, and FIG. 3 shows the LAO activity for changes in NaCl concentration.
Comparing FIGS. 2 and 3, the LAO activity does not become high unless the concentration of NaCl is 0.5 M or higher, whereas the SDS has a low concentration of 0.5 mM to 1.4 mM, that is, the concentration of NaCl. LAO showed high activity at a low concentration of about 1/1000 or less.

図4及び図5は、SDSが高濃度になった場合のLAO活性を確認したものである。
図4は、SDSの1.4mM以下の低濃度におけるLAO活性変化であり、図5は140mMまで高濃度側に変化させたグラフである。
その結果、SDS濃度は0.5mM〜5mM程度の薄い濃度範囲がよく、10mMを超えると、逆にLAO活性が低下した。
4 and 5 show the LAO activity when the SDS concentration is high.
FIG. 4 is a graph showing changes in LAO activity at a low concentration of SDS of 1.4 mM or less, and FIG. 5 is a graph showing changes to the high concentration side up to 140 mM.
As a result, the SDS concentration should be in a thin concentration range of about 0.5 mM to 5 mM, and when it exceeds 10 mM, the LAO activity is conversely decreased.

図6は、ラウリル硫酸アンモニウムの濃度変化に対するLAO活性変化の測定結果を示す。
この結果から、ラルリル硫酸アンモニウムもSDSと同様のLAO活性作用を示した。
図7は、塩化ベンザルコニウムの濃度変化に対するLAO活性変化の測定結果を示す。
塩化ベンザルコニウムは、陽イオン界面活性剤の一種であるが、0.01〜0.04%の低濃度でLAOの活性を示した。
FIG. 6 shows the measurement results of the change in LAO activity with respect to the change in the concentration of ammonium lauryl sulfate.
From this result, ammonium larryl sulfate also showed the same LAO activity as SDS.
FIG. 7 shows the measurement results of the change in LAO activity with respect to the change in the concentration of benzalkonium chloride.
Benzalkonium chloride, which is a type of cationic surfactant, showed LAO activity at a low concentration of 0.01 to 0.04%.

次に、いろいろな試薬を用いてLAO活性を評価した。
その結果、以下の試薬ではLAO活性が認められなかった。
(1)SDS及びラウリル硫酸アンモニウムは、陰イオン性に属する界面活性剤としても使用されていることから、非イオン性の界面活性剤に属する商品名TritonX−100{29−[4−(1,1,3,3−テトラメチルブチル)フェノキシ]−3,6,9,12,15,18,21,24,27−ノナオキサノナコサン−1−オール},及び商品名Tween20(ポリオキシエチレンソルビタンモノラウラート)を0〜2%の濃度範囲で評価したが、LAO活性化作用は微弱であった。
(2)陽イオン性の界面活性剤に属する塩化セチルピリジニウムを評価したが、これはLAO活性を示さなかった。
(3)その他に、尿素,塩化テトラメチルアンモニウムを評価したが、LAO活性化作用は有していなかった。
Next, LAO activity was evaluated using various reagents.
As a result, LAO activity was not observed with the following reagents.
(1) Since SDS and ammonium lauryl sulfate are also used as anionic surfactants, the trade name Triton X-100 {29- [4- (1,1)) belongs to the nonionic surfactants. , 3,3-Tetramethylbutyl) Phenoxy] -3,6,9,12,15,18,21,24,27-Nonaoxanonanacosan-1-ol}, and trade name Tween20 (polyoxyethylene sorbitanmono) Laurat) was evaluated in the concentration range of 0 to 2%, but the LAO activating effect was weak.
(2) Cetylpyridinium chloride, which belongs to a cationic surfactant, was evaluated, but it did not show LAO activity.
(3) In addition, urea and tetramethylammonium chloride were evaluated, but they did not have a LAO activating effect.

以上のことからLAO活性を刺激し、抗菌活性を増強するにはモノアルキル硫酸エステルの塩又は塩化ベンザルコニウムを用いるのが効果的であることが明らかになった。
上記のモノアルキルは炭素数8以上、好ましくは12以上である。
From the above, it was clarified that it is effective to use a salt of monoalkyl sulfate or benzalkonium chloride to stimulate LAO activity and enhance antibacterial activity.
The above monoalkyl has 8 or more carbon atoms, preferably 12 or more carbon atoms.

Claims (4)

魚類における魚病の感染予防又は治療に用いるための、モノアルキル硫酸エステルの塩又は塩化ベンザルコニウムを含有する、魚病の予防及び治療剤。 A preventive and therapeutic agent for fish diseases, which comprises a salt of monoalkyl sulfate or benzalkonium chloride for use in the prevention or treatment of fish disease infection in fish. 前記モノアルキル硫酸エステルの塩はラウリル硫酸ナトリウム又はラウリル硫酸アンモニウムである、請求項1記載の魚病の予防及び治療剤。 The preventive and therapeutic agent for fish diseases according to claim 1, wherein the salt of the monoalkyl sulfate ester is sodium lauryl sulfate or ammonium lauryl sulfate. 魚類に有しているL−アミノ酸オキシダーゼを活性化することで、抗菌活性が得られるものである、請求項1又は2に記載の魚病の予防及び治療剤。 The preventive and therapeutic agent for fish diseases according to claim 1 or 2, wherein antibacterial activity can be obtained by activating L-amino acid oxidase possessed by fish. 魚類の飼育水に請求項1〜3のいずれかの記載の魚病の予防及び治療剤を0.5〜5mMの濃度になるように添加することを特徴とする、魚病の予防及び治療方法。 A method for preventing and treating fish disease, which comprises adding the preventive and therapeutic agent for fish disease according to any one of claims 1 to 3 to the breeding water of fish so as to have a concentration of 0.5 to 5 mM. ..
JP2019117995A 2019-06-26 2019-06-26 Agent for preventing and treating fish disease Pending JP2021004195A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019117995A JP2021004195A (en) 2019-06-26 2019-06-26 Agent for preventing and treating fish disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019117995A JP2021004195A (en) 2019-06-26 2019-06-26 Agent for preventing and treating fish disease

Publications (1)

Publication Number Publication Date
JP2021004195A true JP2021004195A (en) 2021-01-14

Family

ID=74099551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019117995A Pending JP2021004195A (en) 2019-06-26 2019-06-26 Agent for preventing and treating fish disease

Country Status (1)

Country Link
JP (1) JP2021004195A (en)

Similar Documents

Publication Publication Date Title
Woodhams et al. Treatment of amphibians infected with chytrid fungus: learning from failed trials with itraconazole, antimicrobial peptides, bacteria, and heat therapy
Castex et al. Effect of probiotic Pediococcus acidilactici on antioxidant defences and oxidative stress of Litopenaeus stylirostris under Vibrio nigripulchritudo challenge
Mitchell et al. A review of infectious gill disease in marine salmonid fish
RU2529799C2 (en) Compositions for enhancing antibacterial activity of myeloperoxidase and methods of their application
CN108605933B (en) Fatty acid compound
CA2930639C (en) Method for controlling water molds in aquaculture water
CN106999533A (en) Antimicrobial compositions
CN107001989A (en) The clean surface agent of natural origin and disinfectant
JP2021004195A (en) Agent for preventing and treating fish disease
CN101646340B (en) Production of a viable, storable worm egg suspension
JP5598820B2 (en) Vaccine for the prevention and treatment of scotchosis in fish
JP6243482B2 (en) Method for inactivating pathogenic microorganisms
CN104026148A (en) Virus inactivation agent and production process thereof
AU2009211204A1 (en) Antimicrobial agents for the treatment of Campylobacter species in the crop of a bird
He et al. Adaptive evolution in asymptomatic host confers MDR Salmonella with enhanced environmental persistence and virulence
Dutta et al. The effects of stress on respiratory disease and transient colonization of turkeys with Listeria monocytogenes Scott A
TWI546017B (en) Vaccine against vibrio infection in shrimp and preparation method thereof
CN1201464A (en) Helicobacter pylori protein
Sennouni et al. ANTIFUNGAL ACTIVITY OF THYMOL ON PLANKTONIC AND BIOFILM CELLS
Qi et al. Efficient inactivation of African swine fever virus by a highly complexed iodine combined with compound organic acids
RU2501500C1 (en) Method for disinfection of poultry carcasses surface by way of treatment with tm formodez tm water solution
Abdel Kawy et al. Clinical and microbiological aspect of surgical affections associated with current epidemics in bovine
Drasar Problems of the epidemiology of cholera and the ecology of Vibrio cholerae
Kawy Clinical and microbiological aspect of surgical affections
JP2023087650A (en) Hypotonic protective agent for genomic dna of gut microbiota, and preparation method and use thereof